Sensei Biotherapeutics (SNSE) Announces CFO Resignation

On March 27, 2024, Erin Colgan notified Sensei Biotherapeutics (NASDAQ: SNSE) of her resignation from all positions with the Company, including as Chief Financial Officer. Ms. Colgan’s resignation is voluntary and will be effective April 10, 2024, and was not related to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

You May Also Be Interested In

• PPG names three segment leaders effective September 2026
• Olenox signs LOI to acquire Wildboy Holdings and IPD for $20M
• Asia Broadband drops civil suit without prejudice to reassess strategy